Paper41357352
Serum neuronal, glial and mitochondrial markers in autosomal dominant optic atrophy and Leber hereditary optic neuropathy.
Rufa A and 13 others. Brain Commun, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Serum neuronal, glial and mitochondrial markers in autosomal dominant optic atrophy and Leber hereditary optic neuropathy. Papers, record 41357352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41357352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum neuronal, glial and mitochondrial markers in autosomal dominant optic atrophy and Leber hereditary optic neuropathy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36465110 | Astrocyte heterogeneity within white matter tracts and a unique subpopulation of optic nerve head astrocytes. | iScience | 2022 | https://conductscience.org/library/papers/36465110 | PubMed |
| 2 | 31040363 | Propagation and Selectivity of Axonal Loss in Leber Hereditary Optic Neuropathy. | Sci Rep | 2019 | https://conductscience.org/library/papers/31040363 | PubMed |
| 3 | 21112411 | Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. | Prog Retin Eye Res | 2011 | https://conductscience.org/library/papers/21112411 | PubMed |
| 4 | 33298565 | Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/33298565 | PubMed |
| 5 | 26206091 | Reduced mitochondrial Ca(2+) transients stimulate autophagy in human fibroblasts carrying the 13514A>G mutation of the ND5 subunit of NADH dehydrogenase. | Cell Death Differ | 2016 | https://conductscience.org/library/papers/26206091 | PubMed |
| 6 | 26463265 | Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. | Ann Neurol | 2015 | https://conductscience.org/library/papers/26463265 | PubMed |
| 7 | 11909893 | Mitochondrial optic neuropathies. | J Neurol Neurosurg Psychiatry | 2002 | https://conductscience.org/library/papers/11909893 | PubMed |
| 8 | 23891817 | Retinal ganglion cells: Energetics, compartmentation, axonal transport, cytoskeletons and vulnerability. | Prog Retin Eye Res | 2013 | https://conductscience.org/library/papers/23891817 | PubMed |
| 9 | 11579380 | Expression of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. | J Comp Neurol | 2001 | https://conductscience.org/library/papers/11579380 | PubMed |
| 10 | 33157126 | Treatment with GDF15, a TGFβ superfamily protein, induces protective effect on retinal ganglion cells. | Exp Eye Res | 2021 | https://conductscience.org/library/papers/33157126 | PubMed |
| 11 | 16839885 | OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. | Cell | 2006 | https://conductscience.org/library/papers/16839885 | PubMed |
| 12 | 25486875 | Disturbed mitochondrial dynamics and neurodegenerative disorders. | Nat Rev Neurol | 2015 | https://conductscience.org/library/papers/25486875 | PubMed |
| 13 | 36813316 | Mitochondrial optic neuropathies. | Handb Clin Neurol | 2023 | https://conductscience.org/library/papers/36813316 | PubMed |
| 14 | 26438859 | Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in mice. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26438859 | PubMed |
| 15 | 22158479 | A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. | Cell Death Dis | 2011 | https://conductscience.org/library/papers/22158479 | PubMed |
| 16 | 32508832 | Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint. | Front Immunol | 2020 | https://conductscience.org/library/papers/32508832 | PubMed |
| 17 | 34093409 | Retinal Ganglion Cells-Diversity of Cell Types and Clinical Relevance. | Front Neurol | 2021 | https://conductscience.org/library/papers/34093409 | PubMed |
| 18 | 21745197 | High frequency of OPA1 mutations causing high ADOA prevalence in south-eastern Sicily, Italy. | Clin Genet | 2012 | https://conductscience.org/library/papers/21745197 | PubMed |
| 19 | 25796301 | Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene. | J Neurol Sci | 2015 | https://conductscience.org/library/papers/25796301 | PubMed |
| 20 | 16837542 | Short wavelength-automated perimetry compared with standard achromatic perimetry in autosomal dominant optic atrophy. | Br J Ophthalmol | 2006 | https://conductscience.org/library/papers/16837542 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GDF15 | 9518 | PubTator's text mining | https://conductscience.org/library/genes/9518 | NCBI Gene |
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41357352
GET https://conductscience.org/api/papers/v1/41357352/references?page=2